Clinical significance of insulin-like growth factor gene polymorphisms with survival in patients with gastrointestinal stromal tumors
- PMID: 22563535
- PMCID: PMC3341477
- DOI: 10.4174/jkss.2012.82.5.288
Clinical significance of insulin-like growth factor gene polymorphisms with survival in patients with gastrointestinal stromal tumors
Abstract
Purpose: Insulin-like growth factors (IGFs) regulate a wide range of biological functions including cell proliferation, differentiation, and apoptosis through paracrine and autocrine mechanisms. Accordingly, the present study analyzed polymorphisms of IGF genes and their impact on the prognosis for patients with gastrointestinal stromal tumors (GISTs).
Methods: Two hundred-thirteen consecutive patients with GISTs who underwent curative surgery from 5 medical centers were enrolled in the present study. The genomic DNA was extracted from paraffin-embedded tumor tissue, and four IGF-1 (+2995C/A, +533C/T, IVS2-16540A/G, Ex4-177G/C) and one IGF-2 (IVS1+1280A/G) gene polymorphisms were determined using a Sequenom MassARRAY system.
Results: With a median follow-up of 18.4 months, the estimated 5-year relapse-free survival and overall survival rates were 69.9% and 86.7%, respectively. In a multivariate analysis including age, gender, primary site of disease, pathology, and risk stratification, no significant association was observed between the polymorphism of the IGF-1 and IGF-2 genes and survival.
Conclusion: None of the five IGF-1 and IGF-2 gene polymorphisms investigated in this study was found to be an independent prognostic marker for Korean patients with surgically resected GIST. However, further studies on a larger scale are warranted to clarify the role of IGF-1 and IGF-2 gene polymorphisms as a prognostic biomarker for GIST patients.
Keywords: Gastrointestinal stromal tumor; Insulin-like growth factor; Prognosis; Single nucleotide polymorphism.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures
Similar articles
-
Clinical significance of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 gene polymorphisms in patients with gastrointestinal stromal tumors.Asia Pac J Clin Oncol. 2014 Jun;10(2):e40-5. doi: 10.1111/ajco.12068. Epub 2013 Apr 1. Asia Pac J Clin Oncol. 2014. PMID: 23551429
-
No Association of Insulin-like Growth Factor Gene Polymorphisms with Survival in Patients with Colorectal Cancer.Cancer Res Treat. 2011 Sep;43(3):189-94. doi: 10.4143/crt.2011.43.3.189. Epub 2011 Sep 30. Cancer Res Treat. 2011. PMID: 22022297 Free PMC article.
-
Clinical utility of the new American Joint Committee on Cancer staging system for gastrointestinal stromal tumors: current overall survival after primary tumor resection.Cancer. 2011 Nov 1;117(21):4916-24. doi: 10.1002/cncr.26079. Epub 2011 Mar 31. Cancer. 2011. PMID: 21456019
-
Insulin-like growth factors in endometrial function.Gynecol Endocrinol. 1998 Dec;12(6):399-406. doi: 10.3109/09513599809012842. Gynecol Endocrinol. 1998. PMID: 10065165 Review.
-
Imatinib mesylate: in the treatment of gastrointestinal stromal tumours.Drugs. 2003;63(5):513-22; discussion 523-4. doi: 10.2165/00003495-200363050-00005. Drugs. 2003. PMID: 12600228 Review.
Cited by
-
KIT exon 10 variant (c.1621 A > C) single nucleotide polymorphism as predictor of GIST patient outcome.BMC Cancer. 2015 Oct 24;15:780. doi: 10.1186/s12885-015-1817-5. BMC Cancer. 2015. PMID: 26498480 Free PMC article.
-
Diet induced obesity increases the risk of colonic tumorigenesis in mice.Pathol Oncol Res. 2013 Oct;19(4):657-66. doi: 10.1007/s12253-013-9626-0. Epub 2013 Mar 28. Pathol Oncol Res. 2013. PMID: 23536280
References
-
- Furstenberger G, Senn HJ. Insulin-like growth factors and cancer. Lancet Oncol. 2002;3:298–302. - PubMed
-
- Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr. 2001;131(11 Suppl):3109S–3120S. - PubMed
-
- Ryan PD, Goss PE. The emerging role of the insulin-like growth factor pathway as a therapeutic target in cancer. Oncologist. 2008;13:16–24. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous